Incidence, evolution and risk factors of hypophosphatemia in patients with solid tumors receiving ferric carboxymaltose: a retrospective cohort study.

Decruyenaere, Alexander; Kortbeek, Koen; Delanghe, Sigurd; Rottey, Sylvie; Denys, Hannelore; Lapeire, Lore

Decruyenaere, Alexander; Kortbeek, Koen; Delanghe, Sigurd; Rottey, Sylvie; Denys, Hannelore; Lapeire, Lore.

Afiliação

Decruyenaere A; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
Kortbeek K; Department of Medical Oncology, Ghent University Hospital, Ghent, Belgium.
Delanghe S; Department of Medical Oncology, University Hospital Brussels, Brussels, Belgium.
Rottey S; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
Denys H; Department of Nephrology, Ghent University Hospital, Ghent, Belgium.
Lapeire L; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.

Acta Clin Belg ; 78(4): 298-307, 2023 Aug.

Article em En | MEDLINE | ID: mdl-36511107

Assuntos

Anemia Ferropriva; Hipofosfatemia; Neoplasias; Humanos; Estudos Retrospectivos; Incidência; Anemia Ferropriva/tratamento farmacológico; Anemia Ferropriva/epidemiologia; Compostos Férricos/efeitos adversos; Hipofosfatemia/induzido quimicamente; Hipofosfatemia/epidemiologia; Hipofosfatemia/complicações; Fatores de Risco; Neoplasias/complicações; Neoplasias/tratamento farmacológico; Neoplasias/epidemiologia; Fósforo

Palavras-chave

Anemia; cancer; ferric carboxymaltose; hypophosphatemia; intravenous iron; iron deficiency

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hipofosfatemia / Anemia Ferropriva / Neoplasias Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google